These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 21454196

  • 1. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
    Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E.
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M.
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [Abstract] [Full Text] [Related]

  • 3. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.
    Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M.
    Clin Lymphoma; 2005 Mar; 5(4):265-9. PubMed ID: 15794862
    [Abstract] [Full Text] [Related]

  • 5. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
    Ocio EM, del Carpio D, Caballero Á, Alonso J, Paiva B, Pesoa R, Villaescusa T, López-Anglada L, Vidriales B, García-Sanz R.
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA.
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.
    J Clin Oncol; 2005 Jul 20; 23(21):4662-8. PubMed ID: 16034042
    [Abstract] [Full Text] [Related]

  • 9. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M, Hematology/Oncology Studies and Trials (HOST) Group, Italy.
    Semin Oncol; 2003 Apr 20; 30(2):172-7. PubMed ID: 12720131
    [Abstract] [Full Text] [Related]

  • 10. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr 20; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S, Landgren O.
    Best Pract Res Clin Haematol; 2016 Jun 20; 29(2):187-193. PubMed ID: 27825465
    [Abstract] [Full Text] [Related]

  • 12. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A, Schrøder HD, Plesner T, Abildgaard N, Sindrup SH.
    J Neurol Sci; 2015 Feb 15; 349(1-2):60-4. PubMed ID: 25582978
    [Abstract] [Full Text] [Related]

  • 13. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G.
    Clin Cancer Res; 2005 Mar 01; 11(5):1786-90. PubMed ID: 15756000
    [Abstract] [Full Text] [Related]

  • 14. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
    Cesana C, Miqueleiz S, Bernuzzi P, Tresoldi E, Rossi V, D'avanzo G, Filippini D, Morra E.
    Semin Oncol; 2003 Apr 01; 30(2):231-5. PubMed ID: 12720142
    [Abstract] [Full Text] [Related]

  • 15. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA, Kyrtsonis MC, Kontopidou FN, Vassilakopoulos TP, Siakantaris MP, Dimopoulou MN, Kittas C, Angelopoulou MK.
    Semin Oncol; 2003 Apr 01; 30(2):201-5. PubMed ID: 12720136
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.
    Kyle RA, Therneau TM, Dispenzieri A, Kumar S, Benson JT, Larson DR, Melton LJ, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2013 Apr 01; 13(2):184-6. PubMed ID: 23490989
    [Abstract] [Full Text] [Related]

  • 17. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B, Montes MC, García-Sanz R, Ocio EM, Alonso J, de Las Heras N, Escalante F, Cuello R, de Coca AG, Galende J, Hernández J, Sierra M, Martin A, Pardal E, Bárez A, Alonso J, Suarez L, González-López TJ, Perez JJ, Orfao A, Vidríales MB, San Miguel JF.
    Leukemia; 2014 Jan 01; 28(1):166-73. PubMed ID: 23604227
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA, Wilkinson EJ, Gonzalez D, Fenton JA, Short MA, Evans PA, Rawstron AC, Owen RG.
    Clin Lymphoma Myeloma; 2006 Jul 01; 7(1):70-2. PubMed ID: 16879773
    [Abstract] [Full Text] [Related]

  • 19. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
    Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L.
    Br J Haematol; 2019 Nov 01; 187(4):441-446. PubMed ID: 31276195
    [Abstract] [Full Text] [Related]

  • 20. [Significance of monoclonal macroglobulinemia].
    Leporrier M.
    Rev Prat; 1993 Feb 01; 43(3):298-301. PubMed ID: 8502959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.